AU Patent

AU2013361337A1 — 8'-Hydroxy-Dihydroergotamine compounds and compositions

Assigned to MAP Pharmaceuticals Inc · Expires 2015-07-09 · 11y expired

What this patent protects

8'-Hydroxy-Dihydroergotamine (8'-OH DHE) medicinal compounds, compositions, and dosage forms containing such compositions are provided. Also provided herein are methods of treatment, prevention, or amelioration of migraine disorders using the compounds, compositions, dosage forms…

USPTO Abstract

8'-Hydroxy-Dihydroergotamine (8'-OH DHE) medicinal compounds, compositions, and dosage forms containing such compositions are provided. Also provided herein are methods of treatment, prevention, or amelioration of migraine disorders using the compounds, compositions, dosage forms and administration techniques disclosed herein.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013361337A1
Jurisdiction
AU
Classification
—
Expires
2015-07-09
Drug substance claim
No
Drug product claim
No
Assignee
MAP Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.